Close Menu

Looks like people are already warming up for tomorrow's Open Access Day. In the Guardian, Richard Smith pens a column on Springer's acquisition of BioMed Central, which he says may turn out to be a pivotal moment in the history of scientific publishing. "I'm no seer, but it became obvious to me in the mid-90s, when ... I was the chief executive of the BMJ Publishing Group, that the transition to open access would have to happen," he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.